Isomorphic Labs Enters into a Research Collaboration with Johnson & Johnson
Article excerpt
Highlighted: the sentence this signal was extracted from
Isomorphic Labs enters into a research collaboration with Johnson & Johnson. Isomorphic Labs announces a cross-modality, multi-target research collaboration with Johnson & Johnson. This partnership brings together Iso's AI-first approach to drug discovery with Johnson & Johnson's expertise in drug discovery and development. Isomorphic Labs' foundational drug design engine is capable of generating drug candidates against challenging targets across a range of modalities such as small molecules, antibodies, peptides and molecular glues. This collaboration will leverage this multi-modality discovery capability, including large molecule and biologics design. This partnership combines isomorphic Labs' pioneering AI capabilities with Johnson & Johnson's expertise in target biology and drug discovery.
